Dosing Protocol
Typical Dose 40 mg
Range 5 - 40 mg
Maintenance 40 mg daily
Pharmacokinetics
Half-Life 2.0 hrs
Onset 30 min
Peak 1.0 hrs
Duration 6.0 hrs
Bioavailability 90%
Primary Route Subcutaneous
Administration
Routes Subcutaneous, Intravenous
Injection Sites Abdomen, Thigh
Needle Gauge 29-31G
Syringe Type Insulin
Timing Morning
Reconstitution
Diluent Sterile Water
Volume 2 mL
Stability 28 days refrigerated
Vial Sizes 40 mg
Special Instructions
FDA approved for Barth syndrome. Selectively targets mitochondria. Daily dosing for mitochondrial support.